22NW LP’s Psychemedics Corporation PMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-276,034
| Closed | -$442K | – | 21 |
|
|
2025
Q4 | $442K | Hold |
276,034
| – | – | 0.19% | 20 |
|
|
2025
Q3 | $582K | Hold |
276,034
| – | – | 0.27% | 21 |
|
|
2025
Q2 | $618K | Hold |
276,034
| – | – | 0.39% | 21 |
|
|
2025
Q1 | $643K | Hold |
276,034
| – | – | 0.43% | 19 |
|
|
2024
Q4 | $618K | Hold |
276,034
| – | – | 0.39% | 16 |
|
|
2024
Q3 | $638K | Buy |
276,034
+1,616
| +0.6% | +$3.63K | 0.53% | 13 |
|
|
2024
Q2 | $664K | Hold |
274,418
| – | – | 0.57% | 13 |
|
|
2024
Q1 | $804K | Hold |
274,418
| – | – | 0.69% | 13 |
|
|
2023
Q4 | $812K | Hold |
274,418
| – | – | 0.53% | 14 |
|
|
2023
Q3 | $1.09M | Buy |
+274,418
| New | +$1.22M | 0.78% | 14 |
|
|
2021
Q1 | – | Sell |
-75,534
| Closed | -$384K | – | 39 |
|
|
2020
Q4 | $384K | Sell |
75,534
-100
| -0.1% | -$434 | 0.14% | 34 |
|
|
2020
Q3 | $334K | Sell |
75,634
-6,102
| -7% | -$29.7K | 0.17% | 39 |
|
|
2020
Q2 | $454K | Buy |
81,736
+54,336
| +198% | +$303K | 0.25% | 62 |
|
|
2020
Q1 | $166K | Buy |
+27,400
| New | +$231K | 0.13% | 108 |
|
22NW LP's PMD Position: Q1 2026 in Review
22NW LP sold out of Psychemedics Corporation (PMD) in Q1 2026, closing a stake of 276,034 shares — an estimated $442K sold.
22NW LP first reported a position in PMD in Q1 2020 and held it in 14 quarters. The position peaked at $1.09M in Q3 2023. 0 funds tracked by Wall St. Rank hold PMD as of Q1 2026.
- 22NW LP reported no remaining Psychemedics Corporation position as of Q1 2026 after selling out during the quarter.
- 22NW LP sold 276,034 Psychemedics Corporation shares in Q1 2026, an estimated $442K.
- 22NW LP first reported a position in Psychemedics Corporation in Q1 2020 and held it in 14 quarters.
- 22NW LP's Psychemedics Corporation position peaked at $1.09M in Q3 2023.
- 0 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q1 2026.
Based on 22NW LP's 13F filing for Q1 2026, filed 15 May 2026.